1. Home
  2. AHCO vs CDNA Comparison

AHCO vs CDNA Comparison

Compare AHCO & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AdaptHealth Corp.

AHCO

AdaptHealth Corp.

HOLD

Current Price

$10.84

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$37.34

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHCO
CDNA
Founded
2012
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2017
2007

Fundamental Metrics

Financial Performance
Metric
AHCO
CDNA
Price
$10.84
$37.34
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$13.50
$28.00
AVG Volume (30 Days)
1.3M
1.1M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
$3,244,857,000.00
$48,324,000.00
Revenue This Year
$9.00
$16.01
Revenue Next Year
$6.93
$11.31
P/E Ratio
N/A
$752.20
Revenue Growth
N/A
18.93
52 Week Low
$8.51
$11.26
52 Week High
$13.43
$40.47

Technical Indicators

Market Signals
Indicator
AHCO
CDNA
Relative Strength Index (RSI) 55.80 72.16
Support Level $10.80 $15.89
Resistance Level $12.87 $40.47
Average True Range (ATR) 0.40 1.70
MACD 0.05 0.51
Stochastic Oscillator 55.61 77.26

Price Performance

Historical Comparison
AHCO
CDNA

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: